News

From the College of Natural Sciences
Center for Infectious Disease Named for Dr. John Ring LaMontagne

Center for Infectious Disease Named for Dr. John Ring LaMontagne

A research center at The University of Texas at Austin will be renamed for Dr. John Ring LaMontagne, a scientist who combated flu and other infectious diseases to improve public health around the globe. The renaming of the existing Center for Infectious Disease follows more than $7 million in contributions by the LaMontagne community of family, friends and colleagues in celebration of Dr. Montagne's work within the National Institutes of Health (NIH).

Promising New Target in War Against Flu

Promising New Target in War Against Flu

Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus, which causes flu, can overcome one of our body's natural defense mechanisms. That makes this flu protein a potentially good target for antiviral drugs directed against the flu virus

Image credit: Pixabay, via Creative Commons CC0 license.
Bacteria Suppress Their Antibiotic-Resistant Cousins

Bacteria Suppress Their Antibiotic-Resistant Cousins

Researchers studying a dangerous type of bacteria have discovered that the bacteria have the ability to block both their own growth and the growth of their antibiotic-resistant mutants. The discovery might lead to better ways to fight a class of bacteria that have contributed to a growing public health crisis by becoming increasingly resistant to antibiotic treatments.

Two Elected to the American Academy of Arts and Sciences

Two Elected to the American Academy of Arts and Sciences

The American Academy of Arts and Sciences announced this week the election of two new members from The University of Texas at Austin—mathematician Björn Engquist and biochemist George Georgiou.

UT Austin Researchers Evaluate Methodology of Ebola Vaccine Trials

UT Austin Researchers Evaluate Methodology of Ebola Vaccine Trials

Medical aid workers in full protective gearThe waning number of Ebola cases is good news for West Africa, but for those developing a vaccine for the disease, it means time is running short.

HIV Not As Infectious Soon After Transmission As Thought

HIV Not As Infectious Soon After Transmission As Thought

People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives.

New Cystic Fibrosis Research Examines Deadly Pathogen

New Cystic Fibrosis Research Examines Deadly Pathogen

A new method of testing the most common cause of life-threatening infection in people with cystic fibrosis could improve efforts to study and combat the illness.

New Protein Booster May Lead to Better DNA Vaccines and Gene Therapy

New Protein Booster May Lead to Better DNA Vaccines and Gene Therapy

Scientists have discovered a new way to manipulate how cells function, a finding that might help advance an experimental approach to improving public health: DNA vaccines, which could be more efficient, less expensive and easier to store than traditional vaccines.

Silent Ebola Infections Could Be Key to Controlling Outbreak

Silent Ebola Infections Could Be Key to Controlling Outbreak

In a letter published in the Lancet medical journal on October 14, Steve Bellan and Lauren Ancel Meyers, speculate that Ebola may be silently immunizing large numbers of people who never fal ill or infect others. If so, they might bolster front-line health care responses to the ongoing outbreak. Learn more in our press release.

As Ebola Kills Some, It May Be Quietly Immunizing Others

As Ebola Kills Some, It May Be Quietly Immunizing Others

Ebola virus

As Ebola continues to spread in West Africa, it may be silently immunizing large numbers of people who never fall ill or infect others, yet become protected from future infection. If such immunity is confirmed, it would have significant ramifications on projections of how widespread the disease will be and could help determine strategies that health workers use to contain the disease, according to a letter published Tuesday in the Lancet medical journal.